oral glp-1 medications fda approved Wegovy Pill Becomes First Weight-Loss Drug in U.S FDA approves Foundayo, an oral

A recent paper published in The Lancet showed that nearly 20% of participants in lifestyle interventions without medications gain weight, around 40% lose between 1-10% of their body weight, and just 13% lose more than 10%

Ratner, R

Remember, sustainable weight management is about more than just one hormone

The medication is expected to be a blockbuster due to its triple agonism and greater efficacy than tirzepatide and semaglutide

Glycemic Control: Investigations include changes in fasting glucose, post-prandial responses, and HbA1c in metabolic-disease cohorts

6X1A: Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, enel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D